TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19628436

Group type: EXPERIMENTAL
Intervention: Nonsurgical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (baseline non-opioid users)
Number of subjects: 0
Study: 17687635

Group type: EXPERIMENTAL
Intervention: High-dose pravastatin (40 mg/day)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-dose pravastatin (10 mg) + ezetimibe (10 mg)
Number of subjects: 100
Study: 16379629

Group type: EXPERIMENTAL
Intervention: 3 premium diets fed for 4 months each in random order
Number of subjects: 44
Study: 12088694

Group type: EXPERIMENTAL
Intervention: Pain intensity assessment (PIA) condition with CO(2) laser stimuli of 40ms duration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pain intensity assessment (PIA) condition with CO(2) laser stimuli of 60ms duration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pain intensity assessment (PIA) condition with CO(2) laser stimuli of 80ms duration
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control motor task condition (midpoint of VAS line)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intensity assessment-related potential (IAP) under PIA condition
Number of subjects: 12
Study: 9775843

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7599345

Group type: EXPERIMENTAL
Intervention: 1 g bid sucralfate gel
Number of subjects: 368

Group type: COMPARATOR
Intervention: 1 g qid sucralfate suspension
Number of subjects: 368
Study: 3334108

Group type: EXPERIMENTAL
Intervention: Naproxen 375 mg twice daily
Number of subjects: 586

Group type: EXPERIMENTAL
Intervention: Naproxen 750 mg twice daily
Number of subjects: 586
Study: 30775427

Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY) 25 mcg twice daily
Number of subjects: 2379

Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY) 50 mcg twice daily
Number of subjects: 2379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2379

Group type: EXPERIMENTAL
Intervention: Nebulized glycopyrrolate (GLY)
Number of subjects: 2379

Group type: EXPERIMENTAL
Intervention: Tiotropium (TIO; 18 mcg once daily)
Number of subjects: 2379

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 2379
Study: 27609033

Group type: EXPERIMENTAL
Intervention: sWBV (side-alternating whole body vibration) for 14 weeks with ten 9-minute sessions weekly
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no sWBV)
Number of subjects: 24
Study: 26304875

Group type: EXPERIMENTAL
Intervention: Electronic health record‐based trigger algorithms for colorectal cancer
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Electronic health record‐based trigger algorithms for prostate cancer
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Electronic health record‐based trigger algorithms for lung cancer
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Electronic health record‐based trigger algorithms
Number of subjects: 72
Study: 23122184

Group type: EXPERIMENTAL
Intervention: Automated portable device (APD) for measuring toe-brachial index (TBI)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Strain-gauge plethysmography (SGP)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Correlation analysis of absolute toe pressures
Number of subjects: 204
Study: 21358492

Group type: EXPERIMENTAL
Intervention: McKenzie method
Number of subjects: 350

Group type: COMPARATOR
Intervention: Manipulation
Number of subjects: 350
Study: 18231720

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (MXF)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Ampicillin/sulbactam (AMP/SUL)
Number of subjects: 139
Study: 16572920

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg test formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 0
Study: 12473421

Group type: EXPERIMENTAL
Intervention: Center-based exercise (supervised sessions for 6 months)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Center-based exercise
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 126

Group type: COMPARATOR
Intervention: Moderate vs vigorous exercise
Number of subjects: 126
Study: 11166091

Group type: EXPERIMENTAL
Intervention: Apomorphine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9117837

Group type: EXPERIMENTAL
Intervention: Multidisciplinary integrated community and hospital leg ulcer service
Number of subjects: 0
Study: 7914759

Group type: EXPERIMENTAL
Intervention: 5-ASA enemas (4g/100ml)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Oral sulphasalazine (2g/day)
Number of subjects: 31
Study: 3053176

Group type: EXPERIMENTAL
Intervention: Low dose warfarin (mean daily dose of 4.6 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low dose warfarin
Number of subjects: 0
Study: 31715671

Group type: EXPERIMENTAL
Intervention: MDT‐ERAS intervention
Number of subjects: 572
Study: 29072166

Group type: EXPERIMENTAL
Intervention: Protein rich meal during each treatment in the intervention group (IG)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual snack brought from home in the control group (CG)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 99
Study: 23380567

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg daily for 4 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Quinapril 20 mg daily for 4 weeks
Number of subjects: 33
Study: 22477032

Group type: EXPERIMENTAL
Intervention: sorafenib with cryotherapy (cryoRx)
Number of subjects: 104

Group type: COMPARATOR
Intervention: sorafenib
Number of subjects: 104
Study: 20156334

Group type: EXPERIMENTAL
Intervention: Phytalgic (food supplement containing fish oils, urtica dioica, zinc, and vitamin E)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18050198

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 16286607

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment
Number of subjects: 193
Study: 12048081

Group type: EXPERIMENTAL
Intervention: Fast track extubation protocol
Number of subjects: 323

Group type: COMPARATOR
Intervention: Non-fast track extubation protocol
Number of subjects: 323
Study: 10383925

Group type: EXPERIMENTAL
Intervention: Oral dose of 500 mg bosentan (3.7 MBq)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous dose of 250 mg bosentan (3.7 MBq)
Number of subjects: 8
Study: 7801178

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 2679831

Group type: EXPERIMENTAL
Intervention: diazepam 35 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: diazepam 10 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: diazepam (both doses)
Number of subjects: 24
Study: 9125

Group type: EXPERIMENTAL
Intervention: Oxypertine 20 mg orally as a nocturnal sedative and again on the morning of operation
Number of subjects: 185

Group type: COMPARATOR
Intervention: Papaveretum 10 mg
Number of subjects: 185

Group type: COMPARATOR
Intervention: Atropine 0.6 mg
Number of subjects: 185
Study: 31283046

Group type: EXPERIMENTAL
Intervention: Stunted children
Number of subjects: 1981

Group type: EXPERIMENTAL
Intervention: Children who recovered from stunting
Number of subjects: 1981

Group type: EXPERIMENTAL
Intervention: Boys born small for gestational age
Number of subjects: 1981

Group type: COMPARATOR
Intervention: Girls small or appropriate for gestational age at birth
Number of subjects: 1981
Study: 31092024

Group type: EXPERIMENTAL
Intervention: Epidural oxycodone (EPI group; n = 18)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravenous oxycodone (IV group; n = 12)
Number of subjects: 30
Study: 28692172

Group type: EXPERIMENTAL
Intervention: Vitamin D3 100,000 IU monthly
Number of subjects: 452

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Vitamin D3 100,000 IU monthly (with baseline 25-hydroxyvitamin D ≤ 30 nmol L-1)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Vitamin D3 100,000 IU monthly (with baseline 25-hydroxyvitamin D > 30 nmol L-1)
Number of subjects: 452
Study: 25090099

Group type: EXPERIMENTAL
Intervention: Affectionate interaction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Quiet rest with the friend/romantic partner present
Number of subjects: 60

Group type: COMPARATOR
Intervention: Separation from the friend/romantic partner
Number of subjects: 60
Study: 23437781

Group type: EXPERIMENTAL
Intervention: Extended Bipolar (EBP) configuration
Number of subjects: 50

Group type: COMPARATOR
Intervention: True Bipolar (TBP) configuration
Number of subjects: 50
Study: 22043677

Group type: EXPERIMENTAL
Intervention: Moxibustion at Sanyinjiao (SP 6)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-acupoint group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Blank group
Number of subjects: 60
Study: 19688625

Group type: EXPERIMENTAL
Intervention: Fluoroscopy‐based computer assisted technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional fluoroscopic technique
Number of subjects: 0
Study: 16978160

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: No epidural analgesia
Number of subjects: 60
Study: 14622056

Group type: EXPERIMENTAL
Intervention: Study item repetition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantic similarity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthographic similarity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Category length
Number of subjects: 0

Group type: COMPARATOR
Intervention: Massed study time
Number of subjects: 0
Study: 10936668

Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg three times daily)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 9078197

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 1486

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1486
Study: 8470626

Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole plus 4 x 500 mg amoxicillin suspension for 1 wk (group I, n = 35)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 2 x 40 mg omeprazole plus 4 x 500 mg amoxicillin for 1 wk (group II, n = 50)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 2 x 20 mg omeprazole plus 4 x 500 mg amoxicillin for 2 wk (group III, n = 62)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 2 x 20 mg omeprazole (day 1‐14) and 4 x 500 mg amoxicillin (day 8‐14) (group IV, n = 22)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 2 x 20 mg omeprazole for 2 wk (group V, n = 11)
Number of subjects: 180
Study: 3512149

Group type: EXPERIMENTAL
Intervention: 30 mg nalbuphine
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 650 mg acetaminophen
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Combination of nalbuphine and acetaminophen
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 29337024

Group type: EXPERIMENTAL
Intervention: Self-management intervention (n=75)
Number of subjects: 163

Group type: COMPARATOR
Intervention: MS education intervention (n=88)
Number of subjects: 163
Study: 26967465

Group type: EXPERIMENTAL
Intervention: Low-magnitude, high-frequency mechanical stimulation (0.3 g; 32-37 Hz) for 2 sessions lasting 10 minutes each, 7 days per week for 1 year.
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo device used at home.
Number of subjects: 65
Study: 24973176

Group type: EXPERIMENTAL
Intervention: Transnasal esophagoscopy (TNE)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Esophageal capsule esophagoscopy (ECE)
Number of subjects: 184
Study: 22616061

Group type: EXPERIMENTAL
Intervention: Multiple zygomatic implants (Zyg); 28 zygomatic and 5 standard implants placed.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard implants (Stand); 41 standard implants placed, 3 lost.
Number of subjects: 14
Study: 20640365

Group type: EXPERIMENTAL
Intervention: Bilateral balanced occlusion
Number of subjects: 24

Group type: COMPARATOR
Intervention: Canine guidance
Number of subjects: 24
Study: 18328120

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg/HCTZ 12.5 mg
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg/HCTZ 25 mg
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study: 15818078

Group type: EXPERIMENTAL
Intervention: Up-conditioning group
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Down-conditioning group
Number of subjects: 4

Group type: COMPARATOR
Intervention: At-random conditioning group
Number of subjects: 4

Group type: COMPARATOR
Intervention: No-feedback control group
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: N150-P260 pain (event)-related potentials
Number of subjects: 4
Study: 12006795

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10584979

Group type: EXPERIMENTAL
Intervention: 40 mg omeprazole
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 80 mg omeprazole
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8914501

Group type: EXPERIMENTAL
Intervention: Compensatory stepping responses to unpredictable postural perturbations in elderly subjects
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Compensatory stepping responses to unpredictable postural perturbations in young subjects
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison of anticipatory postural adjustments between elderly and young subjects
Number of subjects: 14
Study: 1862209

Group type: EXPERIMENTAL
Intervention: Low dose of fluphenazine decanoate (5 to 10 mg every 2 weeks)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Anxious‐Depression subscale of the Brief Psychiatric Rating Scale (BPRS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Modification of the patient self‐report Early Signs Questionnaire
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Idiosyncratic Prodromal Scale (IPS)
Number of subjects: 50
Study: 6352658

Group type: EXPERIMENTAL
Intervention: Ceftazidime 0.5 g every 12 h for 7 to 10 days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Tobramycin 1 mg/kg every 8 h for 7 to 10 days
Number of subjects: 51
Study: 30985537

Group type: EXPERIMENTAL
Intervention: Acupressure (pressure applied for 6 minutes, three times a day for a maximum of 2 postoperative days)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Sham (extremely light touch applied to acupoints)
Number of subjects: 163

Group type: COMPARATOR
Intervention: No intervention (no touch)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 163

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 163

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 163
Study: 27816497

Group type: EXPERIMENTAL
Intervention: LR + IND
Number of subjects: 192

Group type: COMPARATOR
Intervention: NS + placebo
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: NS + IND
Number of subjects: 192
Study: 26391457

Group type: EXPERIMENTAL
Intervention: Standard of care plus non-invasive vagus nerve stimulation (nVNS)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard of care alone (control)
Number of subjects: 97
Study: 24962473

Group type: EXPERIMENTAL
Intervention: Macitentan 30 mg loading dose on day 1 followed by 10 mg once daily for 3 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Sildenafil 20 mg three times a day for 3 days and a single 20 mg dose on day 4
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both macitentan and sildenafil concomitantly
Number of subjects: 12
Study: 21350044

Group type: EXPERIMENTAL
Intervention: 4 mg oral nicotine lozenge
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19643672

Group type: EXPERIMENTAL
Intervention: Topiramate monotherapy
Number of subjects: 406
Study: 17333521

Group type: EXPERIMENTAL
Intervention: Extended-release oxybutynin 10 mg once daily
Number of subjects: 576

Group type: COMPARATOR
Intervention: Extended-release tolterodine 4 mg once daily
Number of subjects: 576

Group type: COMPARATOR
Intervention: Immediate-release tolterodine 2 mg twice daily
Number of subjects: 576
Study: 15554600

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg for six months
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 11559213

Group type: EXPERIMENTAL
Intervention: Octyl cyanoacrylate tissue adhesive
Number of subjects: 42

Group type: COMPARATOR
Intervention: Monofilament suture
Number of subjects: 42
Study: 9389845

Group type: EXPERIMENTAL
Intervention: 4% mepivacaine 80 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: hyperbaric 0.5% bupivacaine 10 mg
Number of subjects: 200
Study: 8178556

Group type: EXPERIMENTAL
Intervention: SPf66 malaria vaccine
Number of subjects: 537

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 537
Study: 2889303

Group type: EXPERIMENTAL
Intervention: 20 mg betaxolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29289621

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1000 IU/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (MDMs differentiated in the absence of vitamin D)
Number of subjects: 0
Study: 27115491

Group type: EXPERIMENTAL
Intervention: Mindfulness training (very brief focused attention training)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Mindfulness training (very brief training)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 143

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 143

Group type: COMPARATOR
Intervention: Inactive control condition
Number of subjects: 143
Study: 25546420

Group type: EXPERIMENTAL
Intervention: MABGEL (2.5 g of gel daily for 12 days containing 10 or 20 mg/g of each mAb)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 28
Study: 22233394

Group type: EXPERIMENTAL
Intervention: Hypnosis intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 0
Study: 20420544

Group type: EXPERIMENTAL
Intervention: Opiates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Benzodiazepines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant medications (tricyclics and antiseizure)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 0
Study: 17963628

Group type: EXPERIMENTAL
Intervention: EH + MS group
Number of subjects: 187

Group type: COMPARATOR
Intervention: EH + nonMS group
Number of subjects: 187
Study: 15910156

Group type: EXPERIMENTAL
Intervention: Multilevel bullying intervention
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1023
Study: 11940063

Group type: EXPERIMENTAL
Intervention: Phytohaemaglutinin (PHA) stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDM allergen stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 9893415

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 7675045

Group type: EXPERIMENTAL
Intervention: Gluten-free diet with oats (50 to 70 g per day from three sources: two types of wheat-starch flour mixed with oats, muesli containing 60% oats, rolled-oat breakfast cereal)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Gluten-free diet without oats (control group)
Number of subjects: 92
Study: 2301781

Group type: EXPERIMENTAL
Intervention: Combination therapy (atropine sulfate and isoetharine)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Isoetharine alone
Number of subjects: 17
Study: 7008147

Group type: EXPERIMENTAL
Intervention: Diazepam as pre-medication
Number of subjects: 204

Group type: COMPARATOR
Intervention: No sedation (control group)
Number of subjects: 204
Study: 31899882

Group type: EXPERIMENTAL
Intervention: Spinal laser interstitial thermotherapy (SLITT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both SLITT and open surgery
Number of subjects: 80
Study: 30681185

Group type: EXPERIMENTAL
Intervention: Teprenone (150 mg/day)
Number of subjects: 369

Group type: COMPARATOR
Intervention: NSAID only (Control)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Teprenone (150 mg/day) with long-term low-dose aspirin
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Teprenone (150 mg/day) with other NSAIDs
Number of subjects: 369
Study: 27981861

Group type: EXPERIMENTAL
Intervention: CE group
Number of subjects: 40

Group type: COMPARATOR
Intervention: CM group
Number of subjects: 40
Study: 24798789

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 22452898

Group type: EXPERIMENTAL
Intervention: Sputum induction (SI)
Number of subjects: 83
Study: 21067829

Group type: EXPERIMENTAL
Intervention: MK-0677 (25mg/day)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 19034732

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 microg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (IMN) (40 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No treatment (controls)
Number of subjects: 32
Study: 16098428

Group type: EXPERIMENTAL
Intervention: Clopidogrel with hirudin/PPACK
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Clopidogrel with citrate
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 36
Study: 11922255

Group type: EXPERIMENTAL
Intervention: 50% autogenous bone plus 50% demineralized freeze-dried bone allograft (DFDBA group)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 50% autogenous bone plus 50% hydroxyapatite (HA group)
Number of subjects: 10